← back to search

Dirk B. Mendel

Spark Therapeutics (United States) · US

Area of research

Molecular Biology · Epidemiology

Research interest

Research interests include Influenza Virus Research Studies, Receptor Mechanisms and Signaling, Chemical Synthesis and Analysis, and Estrogen and related hormone effects.

h-index

46

citations

11,708

works

92

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Pharmacology of AMG 416 (Velcalcetide), a Novel Peptide Agonist of the Calcium-Sensing Receptor, for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients

Journal of Pharmacology and Experimental Therapeutics 2013cited by 111position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tom Hunter · Amgen (United States)1 papers (2013–2013)Randolph M. Johnson · Portola Pharmaceuticals (United States)1 papers (2013–2013)Derek Maclean · Southampton General Hospital1 papers (2013–2013)Gregory Bell · University of California, San Francisco1 papers (2013–2013)Qun Yin · SAIC-GM (China)1 papers (2013–2013)Felix Karim · Amgen (United States)1 papers (2013–2013)Amos Baruch · Enzo Life Sciences (United States)1 papers (2013–2013)Shawn T. Alexander · Amgen (United States)1 papers (2013–2013)James Tomlinson · Sheffield Teaching Hospitals NHS Foundation Trust1 papers (2013–2013)Julie Janes · Dana-Farber Cancer Institute1 papers (2013–2013)Sarah Walter · University of Southern California1 papers (2013–2013)Jin Dong · AstraZeneca (Australia)1 papers (2013–2013)